Gedeon Richter Polska
Tomasz Németh has a work experience as the CEO of Gedeon Richter Polska since 2008. Before that, they worked in controlling at Richter Gedeon Nyrt. / Magyarország from 2001 to 2002. Currently, they are also serving as the President of Polsko-Węgierska Izba Gospodarcza starting from January 2022.
Tomasz Németh began their education at Budapest Business School from 1997 to 2001, where they earned a Bachelor's degree in Accounting and Finance. Later, they pursued further studies at the University of Warsaw from 2006 to 2008, obtaining a Master's degree in Economics. Finally, in 2012-2013, they attended the University of Illinois at Urbana-Champaign, completing an Executive MBA and earning a Master of Business Administration (MBA) degree.
This person is not in any teams
This person is not in any offices
Gedeon Richter Polska
Gedeon Richter is a multinational company specialising in manufacture of medicines and medicinal products. The starting point for everything it does is an understanding of patients' needs in order to provide efficacious pharmaceutical solutions to allow them to live a healthier and more complete life. In addition, it is important for Gedeon Richter to be close to people whose vocation is the most noble – close to those who help and take care of patients on a daily basis. The firm responds to their needs, expectations, and wishes, so that they can carry out their mission as effectively and efficiently as possible. It all started 130 years ago with a small pharmacy and small-scale laboratory which concentrated on production of organotherapeutic preparations. Despite the initial hardships, hard work led to success. Gedeon Richter is a trustworthy company which, for many years, has steadily invested in research and development, as well as innovation, using the extensive know-how developed over many years. Each day, almost a thousand people employed in research and development work to improve the existing medicines and create high quality new ones. Gedeon Richter Polska, with its registered seat in Grodzisk Mazowiecki, is responsible for manufacturing pharmaceuticals in Poland, as well as for research and development, while the Warsaw Branch manages the promotion and efficient distribution of the pharmaceuticals.